Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Psychiatry Research|May 21, 2019
Can the Positive and Negative Syndrome scale (PANSS) differentiate treatment-resistant from non-treatment-resistant schizophrenia? A factor analytic investigation based on data from the Pattern cohort studyRosana Freitas, Bernardo Dos Santos, Carlo Altamura, et al.
Psychiatry Research|June 9, 2018
Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern studyJosep Maria Haro, Carlo Altamura, Ricardo Corral, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 27, 2009
Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophreniaAndrea Schmitt, Jiri Koschel, Mathias Zink, et al.
Schizophrenia Research|October 4, 2015
Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophreniaAndreas Schreiner, Kaire Aadamsoo, A Carlo Altamura, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 28, 2016
Fast sleep spindle reduction in schizophrenia and healthy first-degree relatives: association with impaired cognitive function and potential intermediate phenotypeClaudia Schilling, Manuel Schlipf, Simone Spietzack, et al.
Schizophrenia Research|May 3, 2016
Reduced oxytocin receptor gene expression and binding sites in different brain regions in schizophrenia: A post-mortem studyStefanie Uhrig, Natalie Hirth, Laura Broccoli, et al.
Neuropsychiatric Disease and Treatment|January 8, 2020
Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with SchizophreniaCristina Domenech, Adriana Pastore, A Carlo Altamura, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 28, 2017
Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysisBritta Galling, Alexandra Roldán, Katsuhiko Hagi, et al.
BMC Psychiatry|February 28, 2016
Investigating the efficacy of an individualized metacognitive therapy program (MCT+) for psychosis: study protocol of a multi-center randomized controlled trialBrooke C Schneider, Martin Brüne, Francesca Bohn, et al.
Schizophrenia (Heidelberg, Germany)|August 24, 2022
Bridging the phenomenological gap between predictive basic-symptoms and attenuated positive symptoms: a cross-sectional network analysisHendrik Müller, Linda T Betz, Joseph Kambeitz, et al.
Pageof 11